RE:RE:RE:RE:RE:Today's NR CBDTSteve made me feel very secure as an investor with his confident manner. First of all, Steve expressed his gratitude to all investors. He thanked all of you for your patience and trust. We started by talking about KAI: Testing has tripled since October, and KAI also continues to test on behalf of film productions. Southern California in particular, with its proximity to the film capital of Los Angeles, is being targeted as a possible location for another lab. There are also plans to open or acquire a laboratory in Canada. We also talked about the Saliva test, which will be the subject of a news item tomorrow. Steve also showed me the different boxes of "KAI Care": different tests for home use, with different applications. When asked by the investors what the profit margins are for the PCR tests, Steve was able to confidently give me 100%. The KAI Saliva test is expected to sell for $170. Regarding the clinics, Steve assured me that it was an important step and that there is much more going on in the background. Steve sees Empower as a "big player" in both mental health and traditional medicine. Regarding the clinics, there will be news soon. It was important to Steve to emphasize that he never gives up and especially during times when others are spending time with family and relaxing a bit, he works even harder. Our conversation took place well after midnight local Canadian time. Our conversation ended with Steve saying, "We will see dollars, not pennies per share"